Freestone Grove Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159 Sell
1
-20,457
-100% -$3.04M ﹤0.01% 915
2026
Q1
$3M Buy
+20,458
New +$3.16M 0.02% 349

Other funds holding XLV

Freestone Grove Partners's XLV Position: Q2 2026 in Review

Freestone Grove Partners reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 100% in Q2 2026, selling an estimated $3.04M and leaving 1 share worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #915.

Freestone Grove Partners first reported a position in XLV in Q1 2026 and has held it in 2 quarters since. The position peaked at $3M in Q1 2026. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Freestone Grove Partners held 1 share of State Street Health Care Select Sector SPDR ETF worth $159 as of Q2 2026.
  • Freestone Grove Partners sold 20,457 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $3.04M.
  • State Street Health Care Select Sector SPDR ETF made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #915 holding.
  • Freestone Grove Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2026 and has held it in 2 quarters since.
  • Freestone Grove Partners's State Street Health Care Select Sector SPDR ETF position peaked at $3M in Q1 2026.
  • 1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.